5 Things in ePharmacy You Need to Know This Friday 12/05/23
www.epharmacynews.com
Industry Updates [๐บ๐ธ] Kenvue, J&J's Consumer-Health Spinoff, Jumps 22% in Public Market Debut Johnson & Johnson's subsidiary, Kenvue, went public on the New York Stock Exchange on May 4 under the ticker symbol KVUE. The pharmaceutical company offered 37.5 million shares of common stock at a price of $16 per share, raising $600 million in its initial public offering (IPO). Kenvue plans to use the funds raised to further develop its pipeline of treatments for autoimmune and inflammatory diseases, including a new drug for psoriasis. The IPO comes as Kenvue seeks to expand its presence in the biotech industry.
5 Things in ePharmacy You Need to Know This Friday 12/05/23
5 Things in ePharmacy You Need to Know Thisโฆ
5 Things in ePharmacy You Need to Know This Friday 12/05/23
Industry Updates [๐บ๐ธ] Kenvue, J&J's Consumer-Health Spinoff, Jumps 22% in Public Market Debut Johnson & Johnson's subsidiary, Kenvue, went public on the New York Stock Exchange on May 4 under the ticker symbol KVUE. The pharmaceutical company offered 37.5 million shares of common stock at a price of $16 per share, raising $600 million in its initial public offering (IPO). Kenvue plans to use the funds raised to further develop its pipeline of treatments for autoimmune and inflammatory diseases, including a new drug for psoriasis. The IPO comes as Kenvue seeks to expand its presence in the biotech industry.